European HALEU Supply Deal: ASPI Subsidiary Inks MOU for 2028 Deliveries
Summary
ASP Isotopes Inc.'s wholly-owned subsidiary, Quantum Leap Energy (QLE), has signed a non-binding Memorandum of Understanding (MOU) with a European nuclear technology company for advanced nuclear fuel supply collaboration. This strategic partnership aims to provide High Assay Low Enriched Uranium (HALEU) with over 10% uranium-235 content, with potential deliveries beginning in 2028 and scaling through 2036. This development is highly significant as securing reliable HALEU supply is a critical challenge for the advanced nuclear industry, positioning QLE as a key player in addressing global demand. The market will now look for definitive agreements and further progress on QLE's planned conversion and enrichment facilities.
At the time of this announcement, ASPI was trading at $5.80 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $677.4M. The 52-week trading range was $3.92 to $14.49. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.